Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2025-05-27 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
Group of companies' accounts made up to 2024-12-31
Regulatory Filings
2025-05-27 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-22 English
Director/PDMR Shareholding
Director's Dealing Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details a 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTION BY A PERSON DISCHARGING MANAGERIAL RESPONSIBILITY ('PDMR')', specifically regarding the grant of share units (PSUs and RSUs) to the CEO, Joe Ciaffoni. This type of insider transaction disclosure falls under regulatory reporting concerning director dealings. While 'Director's Dealing' (DIRS) is a specific category, the document format (RNS notification) and the nature of reporting insider transactions strongly align with the general regulatory disclosure mechanism. However, since the core subject is a transaction by a director/executive, DIRS is the most specific fit among the provided options, as it covers 'Report of personal share transactions by company directors and executives (insider trades)'. The RNS header confirms it is a regulatory announcement, but the content is specifically about director dealing.
2025-05-15 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-14 English
Indivior to Participate in Upcoming Events
Regulatory Filings Classification · 98% confidence The document is an announcement from Indivior PLC regarding their participation in upcoming investor conferences and events. It provides details on dates, locations, and the executives attending, but does not contain the actual presentation materials or financial reports themselves. As it is a regulatory news service (RNS) announcement regarding corporate activities that does not fit into specific categories like M&A or earnings releases, it is classified as a general regulatory filing.
2025-05-13 English
8-K/A
Regulatory Filings
2025-05-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.